These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 34721975)

  • 1. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
    Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
    PeerJ; 2021; 9():e12276. PubMed ID: 34721975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A zinc finger protein gene signature enables bladder cancer treatment stratification.
    Zhang J; Zhang C; Cao P; Zheng X; Yu B; Cao H; Gao Z; Zhang F; Wu J; Cao H; Hao C; Sun Z; Wang W
    Aging (Albany NY); 2021 May; 13(9):13023-13038. PubMed ID: 33962398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer.
    Wu Q; Zheng S; Lin N; Xie X
    BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a novel prognostic signature based on transcription factors in breast cancer by bioinformatics analysis.
    Yang Y; Li Z; Zhong Q; Zhao L; Wang Y; Chi H
    Gland Surg; 2022 May; 11(5):892-912. PubMed ID: 35694087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A bioinformatics analysis of zinc finger protein family reveals potential oncogenic biomarkers in breast cancer.
    An G; Feng L; Hou L; Li X; Bai J; He L; Gu S; Zhao X
    Gene; 2022 Jun; 828():146471. PubMed ID: 35378249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Signature Integrated of Immunoglobulin, Glycosylation and Anti-Viral Genes to Predict Prognosis for Breast Cancer.
    Xu S; Liu Y; Ma H; Fang S; Wei S; Li X; Lu Z; Zheng Y; Liu T; Zhu X; Xu D; Pan Y
    Front Genet; 2022; 13():834731. PubMed ID: 35432482
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of ZNF family genes in prognosis, immunity, and treatment of esophageal cancer.
    Hong K; Yang Q; Yin H; Wei N; Wang W; Yu B
    BMC Cancer; 2023 Apr; 23(1):301. PubMed ID: 37013470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis.
    Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y
    Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a N1-methyladenosine-related risk signature for breast carcinoma by bioinformatics analysis and experimental validation.
    Li L; Yang W; Jia D; Zheng S; Gao Y; Wang G
    Breast Cancer; 2023 Jul; 30(4):666-684. PubMed ID: 37178414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of prognostic melatonin-related lncRNA signature in tumor immune microenvironment and drug resistance for breast cancer.
    Gao SC; Wu MD; Zhang XX; Liu YF; Wang CL
    Asian J Surg; 2023 Sep; 46(9):3529-3541. PubMed ID: 37330302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and immune implications of a novel 7-methylguanosine-related microRNA signature in breast invasive carcinoma: from exploration to validation.
    Li AY; Xiao HN; Zhao ZY; Xiang C; Chen ZY; Wang PX; Xia Y; Yu B; Li H; Xiao T
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9105-9128. PubMed ID: 37171615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Validation of an Immunological Expression-Based Prognostic Signature in Breast Cancer.
    Pei J; Li Y; Su T; Zhang Q; He X; Tao D; Wang Y; Yuan M; Li Y
    Front Genet; 2020; 11():912. PubMed ID: 33193571
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.
    Sun Y; Yang M; Zhang Q
    Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A glycolysis-related signature to improve the current treatment and prognostic evaluation for breast cancer.
    Feng S; Ning L; Zhang H; Wang Z; Lu Y
    PeerJ; 2024; 12():e17861. PubMed ID: 39119106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a prognostic score model for breast cancer based on multi-omics analysis of study on bone metastasis.
    Ren H; Shen X; Xie M; Guo X
    Transl Cancer Res; 2024 May; 13(5):2419-2436. PubMed ID: 38881940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic effect and targets of
    Yuan J; Lin M; Yang S; Yin H; Ouyang S; Xie H; Tang H; Ou X; Zeng Z
    Heliyon; 2024 May; 10(10):e31137. PubMed ID: 38778969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A seven-nuclear receptor-based prognostic signature in breast cancer.
    Wu F; Chen W; Kang X; Jin L; Bai J; Zhang H; Zhang X
    Clin Transl Oncol; 2021 Jul; 23(7):1292-1303. PubMed ID: 33210236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploration of prognostic genes and risk signature in breast cancer patients based on RNA binding proteins associated with ferroptosis.
    Chen X; Yang C; Wang W; He X; Sun H; Lyu W; Zou K; Fang S; Dai Z; Dong H
    Front Genet; 2023; 14():1025163. PubMed ID: 36911389
    [No Abstract]   [Full Text] [Related]  

  • 20. An autophagy-related long non-coding RNA prognostic model and related immune research for female breast cancer.
    Chen J; Li X; Yan S; Li J; Zhou Y; Wu M; Ding J; Yang J; Yuan Y; Zhu Y; Wu W
    Front Oncol; 2022; 12():929240. PubMed ID: 36591508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.